Delivery Order SPE2DR25D2100-SPE2DR26FA1CM
- Not listed
- The Defense Logistics Agency awarded a $2,972.74 delivery order to AmerisourceBergen Drug Corp on October 20, 2025, for the supply of Everolimus 1 mg tablets (60 count). This is a firm fixed price delivery order with an ultimate completion date of October 21, 2025, and represents a non-compete, competitively awarded transaction. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical...
- The Defense Logistics Agency (DLA) awarded a $17,318.52 delivery order to AmerisourceBergen Drug Corp for Everolimus 1 mg tablets (60 count) on October 17, 2025, with an ultimate completion date of October 20, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The pharmaceutical distributor, headquartered in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency awarded a delivery order valued at $26,343.78 to AmerisourceBergen Drug Corp for the supply of Everolimus 5 mg tablets (30-count units) on December 29, 2025, with a completion deadline of December 30, 2025. This firm fixed-price, non-set-aside contract represents a competitive award to support federal pharmaceutical procurement needs. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $3,772.21 to supply Everolimus 0.75 mg tablets (60-count packages) with an ultimate completion date of December 12, 2025. This non-set-aside, competitively awarded delivery order utilizes firm fixed price pricing and represents a single transaction under AmerisourceBergen's larger contract vehicle with DLA. The product will be delivered to the vendor's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a $33,334.25 delivery order to AmerisourceBergen Drug Corp for the supply of Everolimus 1 mg tablets (60-count units) under a firm fixed price contract. The delivery order was issued on December 17, 2025, with an ultimate completion date of December 18, 2025, and the work will be performed at the contractor's facility in Conshohocken, Pennsylvania. This non-competitive award represents a continuation of the government's pharmaceutical procurement through...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Everolimus 10 mg tablets (quantity 30) under a firm fixed-price contract valued at $12,749.86, with an ultimate completion date of December 12, 2025. This non-set-aside award represents a competitively awarded transaction for pharmaceutical supply supporting federal medical procurement needs. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Everolimus 0.25 mg tablets (60-count unit) with a ceiling value of $10,068.17. This firm fixed-price delivery order, which is not set-aside and was competitively awarded, is scheduled for completion by August 28, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,856.17 to AmerisourceBergen Drug Corp for the supply of Everolimus 1 mg tablets (60-count units). This is a firm fixed price, competitively awarded contract with no set-aside designation, representing a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The delivery order carries an ultimate completion date of August 12, 2025, with performance occurring at...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $5,473.37 to AmerisourceBergen Drug Corp for the supply of Everolimus 5 mg tablets (30-count packages) on December 11, 2025, with a completion date of December 12, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award falls under AmerisourceBergen's larger Indefinite...
- The U.S. Defense Department's Medical Supply Chain awarded a $18,147.63 delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Everolimus 10 mg tablets in quantities of 30. The contract was competitively awarded without set-aside restrictions under a firm fixed-price delivery order mechanism, with an ultimate completion date of August 28, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a prime pharmaceutical distributor for federal...
- SPE2DR25D2100Indefinite Delivery Contract
- SPE2DR25D2100-SPE2DR26FA1CMDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $19,964.25 to AmerisourceBergen Drug Corp for the supply of Everolimus 1 mg tablets (60-count packaging) on January 9, 2026, with an ultimate completion date of January 12, 2026. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a subsidiary of Cencora, Inc. (doing business as AmerisourceBergen), a major pharmaceutical distributor that serves as a critical vendor for federal medical procurement across military and veteran healthcare systems. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This comprehensive IDC enables the contractor to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs globally, including specialty medications, brand-name and generic drugs, vaccines, and medical devices. The current delivery order exemplifies the ongoing pharmaceutical procurement needs of the Defense Logistics Agency's medical supply chain in support of Department of Defense healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $20.0k | 1/8/26 |